Jonathan Hirsch

Jonathan Hirsch is the Chief Strategy and Growth Officer at Paradigm since March 2022, focusing on enhancing equitable access to clinical trials for patients. As a co-founder and investor at Synapticure Inc., and in various advisory and investor roles across multiple health-oriented companies, Jonathan is actively involved in advancing innovative healthcare solutions. Prior involvement includes investment and advisory roles at Arbital Health, Frame, Thyme Care, Forta, Viz.ai, Osmind, and Freenome, along with serving as a Senior Advisor at Rubicon Founders. Jonathan obtained an M.Sci. in Biological Sciences from Stanford University and an A.B. in Biology and Political Science from the University of Chicago.